(Updated - December 1, 2017 10:48 AM EST)The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE